(Total Views: 484)
Posted On: 01/29/2021 2:13:26 AM
Post# of 148936
Jan.28, 2021
Coronavirus variant first seen in South Africa identified in South Carolina
https://www.washingtonpost.com/health/2021/01...-carolina/
******************
from yahoo board
"My takes as a doctor working in ICU
overall covid patient is down quite a bit. However remain concerned with some new mutant variant s in UK and California but nothing as scary as South Africa
The variant discovered in South Africa, 501Y.V2, with a mutation called 484, may be escaping some or all of the antibodies people developed against a natural infection – though it's too soon to know whether vaccines will be effected.
".. because the new variants spread a lot faster and perhaps vaccines won’t offer as much protection.
"Looking at blood from 44 South Africans who recovered from COVID-19, more than 90% showed reduced immunity to the new variant, and almost half had no protection at all against it, according to a study published Tuesday though not yet peer-reviewed."
If I had to guess, we ll be looking at higher infection rates going into Feb and March. Fda and cdc will approve a lot of therapeutics now in phase 3 trials including hgen, rlftf and cydy. Vax not clear if they work or will work on mutant variants now and developing in the future."
Coronavirus variant first seen in South Africa identified in South Carolina
https://www.washingtonpost.com/health/2021/01...-carolina/
******************
from yahoo board
"My takes as a doctor working in ICU
overall covid patient is down quite a bit. However remain concerned with some new mutant variant s in UK and California but nothing as scary as South Africa
The variant discovered in South Africa, 501Y.V2, with a mutation called 484, may be escaping some or all of the antibodies people developed against a natural infection – though it's too soon to know whether vaccines will be effected.
".. because the new variants spread a lot faster and perhaps vaccines won’t offer as much protection.
"Looking at blood from 44 South Africans who recovered from COVID-19, more than 90% showed reduced immunity to the new variant, and almost half had no protection at all against it, according to a study published Tuesday though not yet peer-reviewed."
If I had to guess, we ll be looking at higher infection rates going into Feb and March. Fda and cdc will approve a lot of therapeutics now in phase 3 trials including hgen, rlftf and cydy. Vax not clear if they work or will work on mutant variants now and developing in the future."
(1)
(0)Scroll down for more posts ▼
